Recombinant Human IL-18BP protein (His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
C-6*His
Activity
not tested
Cat no : Eg1147
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human IL-18BP protein Thr31-Gly194 (Accession# O95998-2) with a His tag at the C-terminus. |
GeneID | 10068 |
Accession | O95998-2 |
PredictedSize | 18.4 kDa |
SDS-PAGE | 30-50 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
IL-18 binding protein (IL-18BP) is a natural regulatory molecule of the proinflammatory cytokine IL-18. IL-18BP gene is expressed in numerous types of tissues and cells of humans and animals and its expression is regulated by interferon gamma (IFN-gamma). It’s a glycoprotein belonging to the immune globulin superfamily. IL-18BP can effectively inhibit action of IL-18 in vivo and in vitro and is considered as a natural antagonist of IL-18. The imbalance of IL-18/IL-18BP has been noticed in some inflammatory diseases, including rheumatoid arthritis (RA), psoriasis, asthma, lupus erythematosus, multiple sclerosis, atherosclerosis, inflammatory bowel disease (IBD), Crohn’s disease (CD) and so on.
References:
1.Wang F.(2024). Biomed Rep. 9;20(6):87. 2.Muhl H, et al.(2000). Biochem Biophys Res Commun. 267:960–963. 3.Mazodier K, et al.(2005). Blood. 106:3483–3489. 4.Mochol M, et al.(2020). 80:221–225. 5.Park SY, et al.(2022). 10(7):1750.